OPK Earnings & Financial Statements
OPKO Health, Inc.
$1.49
+$0.12(+8.76%)
40
Overall
55
Value
18
Tech
47
Quality
Market Cap
$1.02B
Volume
48.14M
52W Range
$0.98 - $1.75
Target Price
$2.67
OPK earnings and financial statements: OPKO Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OPK Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $606.88M | $713.14M | $863.50M | $1.00B | $1.77B |
| Cost of revenue | $400.94M | $494.63M | $545.37M | $715.98M | $1.19B |
| Operating income | -$117.41M | -$152.06M | -$157.02M | -$226.25M | $18.75M |
| EBITDA | -$36.07M | $137.24M | -$64.40M | -$270.03M | $83.57M |
| Net income | -$225.68M | -$53.22M | -$188.86M | -$328.40M | -$30.14M |
| EPS (diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B |
| Total liabilities | $663.99M | $834.76M | $622.48M | $605.61M | $714.59M |
| Shareholders’ equity | $1.27B | $1.37B | $1.39B | $1.56B | $1.69B |
| Cash and equivalents | - | - | $95.88M | $153.19M | $134.71M |
| Long-term debt | $368.27M | $468.03M | $268.46M | $238.33M | $221.03M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$178.54M | -$183.49M | -$28.20M | -$95.19M | $38.34M |
| Capital expenditure | -$11.99M | -$24.77M | -$16.27M | -$24.58M | -$32.16M |
| Free cash flow | -$190.82M | -$208.50M | -$44.47M | -$119.77M | $6.18M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OPK | $1.49 | +8.8% | 48.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |